Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen in the nitrogen containing substituent
Reexamination Certificate
2007-04-17
2007-04-17
Habte, Kahsay (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Chalcogen in the nitrogen containing substituent
C544S090000
Reexamination Certificate
active
11217892
ABSTRACT:
The present invention provides novel methods for the synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one of formula (III)which is useful as a human immunodeficiency virus (HIV) reverse transcriptase inhibitor.
REFERENCES:
patent: 5922864 (1999-07-01), Frey et al.
Pierce et al. J. Org. Chem. 1998, 63, 8536-8543.
Pierce et al., “Practical Asymmetric Synthesis of Efavirenz (DMP 266), and HIV-1 Reverse Transcriptase Inhibitor”, J. Org. Chem., vol. 63, p. 8536-8543, 1998.
Radesca et al., “Synthesis of HIV-1 Reverse Transcriptase Inhibitor DMP 266”, Synthetic Communications, vol. 27(24), pp. 4373-4384, 1997.
Chadwick Scott T.
Costello Carrie A.
Desikan Sridhar
Reiff Emily A.
Vemishetti Purushotham
Bristol--Myers Squibb Company
Chapman Jennifer Chin
Habte Kahsay
VanAtten Mary K.
LandOfFree
Synthesis of a benzoxazinone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthesis of a benzoxazinone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis of a benzoxazinone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3804850